Filters

BCL9 Antibody, Cy7 Conjugated

BCL9 Antibody, Cy7 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy7 Conjugated, BCL9 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenBCL9
SpecificityThis is a highly specific antibody against BCL9
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic peptide derived from human BCL9
Gene ID number101060700
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Bcl-9L exists as multiple alternatively spliced isoforms and is thought to be involved in tumorigenesis, Bcl-9L functions as a transcriptional activator that forms a complex with Parafibromin and Î, Expressed in breast tissue, Jacobsen syndrome, Jervell and Lange-Nielsen syndrome, Niemann-Pick disease, The gene encoding Bcl-9L maps to human chromosome 11, as well as in eye, hereditary angioedema and Smith-Lemli-Opitz syndrome are associated with defects in genes that maps to chromosome 11, lung, possibly playing a role in tumor transformation and metastasis, prostate and various carcinomas, which houses over 1, ², ², -catenin, -catenin and is thought promote the transcriptional activity of Parafibromin and enhance the neoplastic transforming activity of Î, 400 genes and comprises nearly 4% of the human genome, 499 amino acid protein that localizes to the nucleus and contains a specialized C-terminal domain that is important for its overall activity, Bcl-9L is a 1
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetBCL9 Conjugated
Short name Conjugated, BCL9 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, B-cell CLL/lymphoma 9 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target BCL9 and IDBG-101829 and ENSG00000116128 and 607, BCL9 and IDBG-633778 and ENSBTAG00000002422 and 788729, Bcl9 and IDBG-176803 and ENSMUSG00000038256 and 77578, LGS, beta-catenin binding, nuclei, this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005801 and cis- this GO lgi network and cellular component this GO :0008013 and beta-catenin binding and molecular function this GO :0014908 and myotube differentiation involved in skeletal muscle regeneration and biological process this GO :0035019 and somatic stem cell maintenance and biological process this GO :0035914 and skeletal muscle cell differentiation and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0060070 and canonical Wnt signaling pathway and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding and also this GO :0008013: beta-catenin binding, this GO :0008013: beta-catenin binding, B-cell CLL/lymphoma 9
Identity 1008
Gene BCL9
Long gene name B-cell CLL/lymphoma 9
Locus 1q21, 2
Discovery year 1997-07-01
GenBank acession Y13620
Entrez gene record 607
Pubmed identfication 9490669
RefSeq identity NM_004326
Havana BLAST/BLAT OTTHUMG00000014031

Subscribe to our Newsletter